文献速递痛风与晶体性关节病

痛风发作与静脉血栓栓塞风险

Risk of Venous Thromboembolism With Gout Flares.
PubMed 文献 · Arthritis Rheumatol · 2023-06-15

基于英国临床实践研究数据链的自身对照病例系列分析纳入314例痛风患者,评估痛风发作与静脉血栓栓塞(VTE)的时间关联。痛风发作后90天暴露期内VTE发生率显著高于基线期(校正IRR 1.83,95%CI 1.30-2.59),其中发作后前30天风险最高(校正IRR 2.31,95%CI 1.39-3.82),第31-60天和第61-90天未见显著升高。

要点

  • 痛风发作后90天内VTE发生率较基线期显著升高(校正IRR 1.83,95%CI 1.30-2.59)。
  • 痛风发作后前30天VTE风险最高(校正IRR 2.31,95%CI 1.39-3.82)。
  • 发作后第31-60天和第61-90天VTE风险较基线无显著升高。

核心结论

  • 痛风患者在接受初级保健就诊或住院治疗痛风发作后30天内,VTE发生率出现一过性升高。

研究设计与样本

  • 自身对照病例系列分析,数据来自英国临床实践研究数据链的电子初级保健记录,并链接住院和死亡登记数据。
  • 共314例患者符合纳入标准(年龄≥18岁、新发痛风、暴露前期间开始前无VTE或初级保健抗凝处方使用)。
  • 暴露期为痛风发作初级保健就诊或住院后90天,分为三个30天区间;基线期为暴露期开始前至结束后各最多2年。
  • 分析校正了季节和年龄,采用校正发病率比(IRR)及95%置信区间(95%CI)衡量关联。

主要发现

  • 暴露期VTE发生率显著高于基线期(校正IRR 1.83,95%CI 1.30-2.59)。
  • 痛风发作后前30天VTE的校正IRR为2.31(95%CI 1.39-3.82),相对基线期显著升高。
  • 第31-60天校正IRR为1.49(95%CI 0.79-2.81),第61-90天校正IRR为1.67(95%CI 0.91-3.06),相对基线期均未达统计学显著。
  • 敏感性分析结果一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous studies demonstrated that the risk of venous thromboembolism (VTE) is increased in patients with gout, but not whether there was a temporal association between gout flare and VTE. This study was undertaken to evaluate potential temporal associations between gout flare and VTE. METHODS: Data were obtained from electronic primary-care records from the UK's Clinical Practice Research Datalink, which links data from hospitalization and mortality registers. Using self-controlled case series analysis adjusted for season and age, we evaluated the temporal association between gout flare and VTE. The 90 days after primary-care consultation or hospitalization for gout flare was designated the exposed period. This was divided into three 30-day intervals. The baseline period was up to 2 years before the start of and up to 2 years after the end of the exposed period. The association between gout flare and VTE was measured using adjusted incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs). RESULTS: In total, 314 patients met the inclusion criteria (age ≥18 years, incident gout, no presence of VTE or use of a primary-care anticoagulant prescription before the start of the pre-exposure period). Among the 314 patients, VTE incidence was significantly higher in the exposed period than in the baseline period (adjusted IRR 1.83, 95% CI 1.30-2.59). The adjusted IRR of VTE during the first 30 days after gout flare was 2.31 (95% CI 1.39-3.82) relative to the baseline period. No increase in the adjusted IRRs was observed in days 31-60 (adjusted IRR 1.49, 95% CI 0.79-2.81) and days 61-90 (adjusted IRR 1.67, 95% CI 0.91-3.06) relative to baseline. Results were consistent across sensitivity analyses. CONCLUSION: Among patients with gout, there was a transient increase in the rate of VTE within 30 days after primary-care consultation or hospitalization for gout flare.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Cipolletta E, Tata LJ, Nakafero G, et al. Risk of Venous Thromboembolism With Gout Flares. Arthritis Rheumatol. 2023. PMID: 36808284. doi:10.1002/art.42480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。